A US-based, top global multinational pharmaceutical company approached Freyr to assist them with filing original IND submissions to the USFDA. Freyr was challenged to work on significant volumes of documents, under defined timelines.
Freyr’s team assisted the customer with end-to-end publishing activities and delivered the IND submissions very quickly.
Understand how Freyr provided the customer with original IND submissions without any errors and warnings while filing the submissions on time. Download the proven case.